In a 21‑year‑old patient with systemic lupus erythematosus (SLE) and Tetralogy of Fallot, is dengue fever a manifestation of SLE or merely a trigger for an SLE flare?

Dengue as Trigger, Not Manifestation of SLE

Dengue fever is an infectious trigger for SLE flares, not a manifestation of the disease itself. In your 21-year-old patient with established SLE and Tetralogy of Fallot, the dengue infection represents a separate viral illness that can precipitate lupus activity through immune system activation.

Understanding the Relationship

Dengue virus infection acts as an environmental trigger that can:

• Initiate SLE in genetically predisposed individuals - Case reports demonstrate dengue evolving into new-onset SLE within weeks of acute infection 1, 2
• Precipitate flares in established SLE - The viral infection causes immune dysregulation and antibody production that can activate dormant lupus 3, 4
• Mimic SLE clinically - Both conditions share fever, arthralgia, rash, thrombocytopenia, and leucopenia, creating diagnostic confusion 5, 4

The mechanism involves dengue viremia inciting excessive antibody production, leading to immune complex deposition that triggers autoimmune responses in susceptible individuals 1.

Critical Diagnostic Pitfalls

Be aware that false-positive dengue IgM can occur in SLE patients 5. When your patient presents with acute febrile illness:

• Overlapping features favor dengue: Retro-orbital pain, abdominal pain, marked thrombocytopenia
• Features suggesting lupus flare: New vasculitis, nephritis, serositis, severe cytopenias with positive anti-dsDNA and low complement 6
• Request dengue serology but don't wait for results if lupus flare seems more likely clinically 4

Management Approach

Since SLE patients have increased infection risk due to immunosuppression 7, 8, your treatment strategy must address both possibilities:

If Dengue is Confirmed:

1. Provide supportive care - Hydration, monitoring for hemorrhagic complications
2. Continue hydroxychloroquine - Do not discontinue antimalarials during infection 8, 9
3. Minimize immunosuppression temporarily if infection is severe
4. Monitor closely for lupus flare developing 2-4 weeks post-dengue 1

If Lupus Flare is Suspected:

1. Assess disease activity using clinical manifestations (new rash, arthritis, serositis, nephritis) and laboratory markers (CBC, creatinine, proteinuria, complement, anti-dsDNA) 6
2. Initiate or increase glucocorticoids if inflammatory manifestations predominate 6
3. Add immunosuppressive therapy (azathioprine, mycophenolate, or methotrexate) for steroid-sparing effect 6, 10
4. Treat specific organ involvement - For cardiac manifestations like the pancarditis reported in dengue-triggered SLE, corticosteroids with immunosuppressants show favorable response 3

Special Consideration for Tetralogy of Fallot:

Your patient's congenital heart disease adds complexity. The cardiac guidelines 11, 12 emphasize monitoring for arrhythmias and ventricular dysfunction, but don't specifically address infection management. Avoid NSAIDs given the cardiac condition and potential for renal involvement in SLE 6.

Monitoring Strategy

Assess infection risk factors at each visit: severe neutropenia (<500 cells/mm³), severe lymphopenia (<500 cells/mm³), low IgG (<500 mg/dL), and current immunosuppressive regimen 7.

For this patient, screen for tuberculosis before intensifying immunosuppression and ensure pneumococcal vaccination when clinically stable 7, 13, 7.

Bottom Line

Treat the dengue infection supportively while remaining vigilant for lupus flare development. The dengue virus serves as an immunological trigger rather than being part of the SLE disease spectrum itself. Most patients who develop lupus manifestations post-dengue do so within 2-4 weeks of acute infection 1, 2, requiring close rheumatologic follow-up during this window.